跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHESGO SC pertuzumab (rch) 600 mg and trastuzumab (rch) 600mg in 10mL solution for injection, vials - TGA Drug Approval Details
Approvals
/
TGA
/
PHESGO SC pertuzumab (rch) 600 mg and trastuzumab (rch) 600mg in 10mL solution for injection, vials
Approved
STANDARD
PHESGO SC pertuzumab (rch) 600 mg and trastuzumab (rch) 600mg in 10mL solution for injection, vials
Roche Products Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
8c73a4a6d8eb6284
Company
Roche Products Pty Ltd
Type
Standard
Approval Details
Approval Id
8c73a4a6d8eb6284
Product Name
PHESGO SC pertuzumab (rch) 600 mg and trastuzumab (rch) 600mg in 10mL solution for injection, vials
Artg Id
332181
Artg Name
PHESGO SC pertuzumab (rch) 600 mg and trastuzumab (rch) 600mg in 10mL solution for injection, vials
Sponsor
Roche Products Pty Ltd
Company Detail Path
/organization/roche-products-pty-ltd
Artg Date
2021-07-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
8c73a4a6d8eb6284
Type
Standard
Back to TGA Approvals